Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Launch of Newdeal Foot and Ankle Implants and United States Introduction of the CALCANEA® Plate
Integra LifeSciences Announces Launch of Newdeal Foot and Ankle Implants and United States Introduction of the CALCANEA(R) Plate PLAINSBORO, N.J., Feb. 16, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has begun selling Newdeal® foot and
View HTML
Toggle Summary Integra LifeSciences Announces First Implantation of the HINTEGRA® Total Ankle Prosthesis in Brazil
Integra LifeSciences Announces First Implantation of the HINTEGRA(R) Total Ankle Prosthesis in Brazil PLAINSBORO, N.J., Feb. 10, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the first three HINTEGRA® Total Ankle Prostheses, a product of
View HTML
Toggle Summary Integra LifeSciences Closes Acquisition of Newdeal Technologies: Leading Marketer of Products for Reconstructive Surgery
Integra LifeSciences Closes Acquisition of Newdeal Technologies: Leading Marketer of Products for Reconstructive Surgery PLAINSBORO, N.J., Jan. 3, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the Newdeal group of companies
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Appoints Anne M. VanLent to its Board of Directors
Integra LifeSciences Holdings Corporation Appoints Anne M. VanLent to its Board of Directors PLAINSBORO, N.J., Dec. 20, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that effective immediately it has increased the size of its Board of Directors to seven
View HTML
Toggle Summary Integra LifeSciences Announces Agreement to Acquire Newdeal Technologies: Leading Marketer of Products for Reconstructive Surgery
Integra LifeSciences Announces Agreement to Acquire Newdeal Technologies: Leading Marketer of Products for Reconstructive Surgery PLAINSBORO, N.J., Nov. 14, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has agreed to acquire the Newdeal group of
View HTML
Toggle Summary Integra LifeSciences Announces Third Quarter 2004 Financial Results
Integra LifeSciences Announces Third Quarter 2004 Financial Results PLAINSBORO, N.J., Nov. 7, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its third quarter revenues and earnings. Total revenues in the third quarter of 2004 increased by $12.1 million to
View HTML
Toggle Summary Integra LifeSciences to Host Analyst Forum on November 15, 2004
Integra LifeSciences to Host Analyst Forum on November 15, 2004 PLAINSBORO, N.J., Nov. 2, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Monday, November 15, 2004 at 3:00 PM Eastern Time at the Hilton Times Square
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Monday, November 8 to Discuss Third Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Monday, November 8 to Discuss Third Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 25, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference
View HTML
Toggle Summary Integra NeuroSciences™ Launches MAYFIELD® Infinity Support System
Integra NeuroSciences(TM) Launches MAYFIELD(R) Infinity Support System PLAINSBORO, N.J., Oct. 19, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell the MAYFIELD® Infinity Support System in the United States through its Integra
View HTML
Toggle Summary Integra Epilepsy™ Products Receive CE Mark For Distribution in the European Union
Integra Epilepsy(TM) Products Receive CE Mark For Distribution in the European Union PLAINSBORO, New Jersey, Oct. 19, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it was awarded the CE Mark required for commercial distribution of the Integra
View HTML